Skip to content Skip to footer

Majority of Canadian patients accessing cannabis on the recreational and black markets

Majority of Canadian patients accessing cannabis on the recreational and black markets
Share this story
Share on twitter
Share on linkedin
Share on email

Our proprietary consumer survey, conducted between March and May 2020, shows that over 15% of the Canadian adult population uses cannabis for medicinal reasons.

The survey covered patients using medical cannabis following a recommendation by a physician, as well as patients sourcing from adult-use dispensaries, friends, or the black market. As of September 2019, there were 369,614 medical cannabis registrations, although a single patient can have multiple registrations with different licensed producers.

Data shows that many users with health conditions source cannabis from legal recreational outlets, friends or the black market, and self-treat with limited medical supervision. Access by these quasi-medical users, generally employing cannabis to tackle mild conditions, is hindered by bureaucratic hurdles making access through other sources more straightforward, as well as by the lack of reimbursement policies making medical cannabis a more expensive option for patients than adult-use, black market or informal cannabis providers.

Recent posts
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad

Catch up on our newest articles that you might have missed

Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...
thomas-kelley--8iE9ykf3Us-unsplash
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad
The recent publishing of the list of CBD products with a valid Novel Foods application by the UK’s Food Safety...